-$1.04 Earnings Per Share Expected for Polarityte Inc (PTE) This Quarter
Wall Street brokerages expect Polarityte Inc (NASDAQ:PTE) to report earnings per share of ($1.04) for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for Polarityte’s earnings, with estimates ranging from ($1.15) to ($0.82). Polarityte reported earnings per share of ($2.31) in the same quarter last year, which would indicate a positive year over year growth rate of 55%. The business is expected to issue its next quarterly earnings report on Monday, April 15th.
According to Zacks, analysts expect that Polarityte will report full-year earnings of ($4.14) per share for the current year, with EPS estimates ranging from ($4.65) to ($3.45). For the next financial year, analysts anticipate that the company will report earnings of ($3.68) per share, with EPS estimates ranging from ($3.85) to ($3.39). Zacks’ EPS calculations are an average based on a survey of research analysts that follow Polarityte.
Polarityte (NASDAQ:PTE) last issued its quarterly earnings results on Monday, January 14th. The company reported ($0.96) earnings per share for the quarter, topping analysts’ consensus estimates of ($1.02) by $0.06. The company had revenue of $1.13 million during the quarter, compared to analyst estimates of $0.80 million. Polarityte had a negative net margin of 4,259.44% and a negative return on equity of 258.52%.
An institutional investor recently bought a new position in Polarityte stock. Comprehensive Portfolio Management LLC bought a new position in Polarityte Inc (NASDAQ:PTE) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 21,702 shares of the company’s stock, valued at approximately $232,000. Comprehensive Portfolio Management LLC owned approximately 0.10% of Polarityte at the end of the most recent reporting period. Institutional investors own 54.85% of the company’s stock.
Shares of NASDAQ:PTE traded down $0.20 during trading on Monday, reaching $8.61. The company had a trading volume of 424,600 shares, compared to its average volume of 345,313. The firm has a market cap of $190.74 million, a P/E ratio of -1.77 and a beta of 1.48. Polarityte has a twelve month low of $8.46 and a twelve month high of $41.22. The company has a current ratio of 13.80, a quick ratio of 13.76 and a debt-to-equity ratio of 0.01.
Polarityte Company Profile
PolarityTE, Inc, a biotechnology and regenerative biomaterials company, focuses on discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine and Contract Services.
Featured Article: Why is the conference call important?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Polarityte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polarityte and related companies with MarketBeat.com's FREE daily email newsletter.